Legal Representation
Attorney
Janet L. Cullum
USPTO Deadlines
Application History
22 events| Date | Code | Type | Description |
|---|---|---|---|
| Oct 15, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Oct 14, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Mar 8, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Mar 6, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Mar 6, 2019 | EXT1 | S | SOU EXTENSION 1 FILED |
| Mar 6, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Sep 11, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Jul 17, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Jul 17, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Jun 27, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jun 7, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jun 6, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jun 6, 2018 | GNEA | O | EXAMINERS AMENDMENT E-MAILED |
| Jun 6, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Jun 6, 2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| May 21, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| May 21, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN |
| May 21, 2018 | GNRT | F | NON-FINAL ACTION E-MAILED |
| May 21, 2018 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Feb 15, 2018 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Feb 14, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Feb 9, 2018 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 042
Medical and scientific research services in the fields of ophthalmology and dermatology; scientific research services for medical purposes in the field of immunology and immunomodulatory formulations; research and development services in the field of nano and small molecule therapies; providing scientific research information in the fields of dermatology and ophthalmology; development of new technology for others in the fields of biocide sterilizing systems and active ingredient manufacturing; Design and development of biocide sterilizing systems and active pharmaceutical ingredients therefor
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of two lines of text in which the word "realm" is on the top line, "therapeutics" is on the bottom line and a flower design is just to the right and above the text.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"THERAPEUTICS"